UnitedHealth shares owned by Capital Research Global Investors
Quarter-by-quarter ownership of UnitedHealth (UNH) shares owned by Capital Research Global Investors
from 13F filings
Historical chart of Capital Research Global Investors investment in UnitedHealth
Tip: Access up to 7 years of quarterly data
All positions including UnitedHealth held by Capital Research Global Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in UnitedHealth by Capital Research Global Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $7.5B | 15M | 504.19 |
| 2023-06-30 | $6.9B | 14M | 480.64 |
| 2023-03-31 | $7.0B | 15M | 472.59 |
| 2022-12-31 | $9.2B | 17M | 530.18 |
| 2022-03-31 | $9.8B | 19M | 509.98 |
| 2021-12-31 | $8.9B | 18M | 502.14 |
| 2021-09-30 | $7.0B | 18M | 390.75 |
| 2021-06-30 | $7.3B | 18M | 400.44 |
| 2021-03-31 | $7.1B | 19M | 372.07 |
| 2020-12-31 | $7.7B | 22M | 350.68 |
| 2020-09-30 | $6.9B | 22M | 311.77 |
| 2020-06-30 | $6.8B | 23M | 294.95 |
| 2020-03-31 | $5.7B | 23M | 249.38 |
| 2019-12-31 | $8.8B | 30M | 293.98 |
| 2019-09-30 | $4.9B | 23M | 217.32 |
| 2019-06-30 | $5.4B | 22M | 244.01 |
| 2019-03-31 | $4.4B | 18M | 247.26 |
| 2018-12-31 | $4.8B | 19M | 249.12 |
| 2018-09-30 | $5.1B | 19M | 266.04 |
| 2018-06-30 | $6.0B | 25M | 245.34 |
| 2018-03-31 | $4.8B | 23M | 214.00 |
| 2017-12-31 | $4.5B | 20M | 220.46 |
| 2017-03-31 | $3.8B | 23M | 164.01 |
| 2016-12-31 | $4.1B | 26M | 160.04 |
| 2016-09-30 | $4.1B | 29M | 140.00 |
| 2016-06-30 | $4.1B | 29M | 141.20 |
| 2016-03-31 | $3.7B | 29M | 128.90 |
| 2015-12-31 | $3.3B | 28M | 117.64 |
| 2015-09-30 | $3.2B | 28M | 116.01 |
| 2015-03-31 | $3.2B | 27M | 118.29 |
| 2014-12-31 | $2.9B | 28M | 106.25 |
| 2014-06-30 | $2.3B | 29M | 81.75 |
| 2013-12-31 | $2.8B | 37M | 75.30 |
| 2013-09-30 | $2.5B | 35M | 71.61 |
| 2013-06-30 | $2.2B | 34M | 65.48 |
More positions owned by Capital Research Global Investors
View all positions for Capital Research Global Investors